Xu Zhenyu 4
4 · SOPHiA GENETICS SA · Filed May 20, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CSO Xu Zhenyu Sells 608 Shares
What Happened
- Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), sold 608 shares in open‑market transactions on May 19, 2026. The reported weighted average sale price was $4.60 per share, for total proceeds of approximately $2,798. This was a sale (not a purchase or exercise).
Key Details
- Transaction date: 2026-05-19.
- Shares sold: 608; weighted average price reported: $4.60; total proceeds: ~$2,798.
- Reported price range: $4.54 to $4.66 across multiple trades (footnote F2 — Reporting Person can provide a price-by-price breakdown on request).
- Purpose: Shares were sold to satisfy tax withholding obligations from restricted stock units that vested May 18, 2026 (footnote F1).
- Trades executed pursuant to a pre-established Rule 10b5‑1(c) plan and were non‑discretionary per the filing.
- Shares owned after the transaction: not disclosed in the provided filing.
- Filing date: 2026-05-20 (filed the day after the transaction; appears timely).
Context
- These sales were specifically to cover tax withholding on RSU vesting and were done under a 10b5‑1 plan, which is a routine and structured way insiders liquidate shares for tax or diversification needs. Such transactions do not, by themselves, indicate management sentiment about the company.
Insider Transaction Report
Form 4
Xu Zhenyu
Chief Scientific Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-05-19$4.60/sh−608$2,798→ 626,280 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Zhenyu Xu|2026-05-20